Angiopoietin-1 is regulated by miR-204 and contributes to corneal neovascularization in KLEIP-deficient mice

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 7, 2014, Pages 4295-4303

  Kather, Jakob N ^a,b   Friedrich, Julian ^c   Woik, Nicole ^a,b   Sticht, Carsten ^a   Gretz, Norbert ^a   Hammes, Hans Peter ^c   Kroll, Jens ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiopoietin 1; Corneal neovascularization; KLEIP KLHL20; miR 204

Indexed keywords

ANGIOPOIETIN 1; MICRORNA; MICRORNA 204; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA NEOVASCULARIZATION; CORNEA STROMA; DYSTROPHY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANGIOPOIETIN-1; CORNEAL NEOVASCULARIZATION; KLEIP; KLHL20; MIR-204;

ANGIOGENESIS INHIBITORS; ANGIOPOIETIN-1; ANIMALS; BLOTTING, WESTERN; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTRAVITREAL INJECTIONS; MICE; MICE, KNOCKOUT; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904296460     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13619     Document Type: Article

References (47)

1. DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg. 2011;37:588-598.
2. Qazi Y, Wong G, Monson B, Stringham J, Ambati BK. Corneal transparency: genesis, maintenance and dysfunction. Brain Res Bull. 2010;81:198-210.
3. Chang JH, Garg NK, Lunde E, Han KY, Jain S, Azar DT. Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol. 2012;57:415-429.
4. Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43:245-269.
5. Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242-249.
6. Ellenberg D, Azar DT, Hallak JA, et al. Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res. 2010;29:208-248.
7. Wuest TR, Carr DJ. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med. 2010;207:101-115.
8. Kim SJ, Lee JW, Yeo ED, et al. The role of Nod1 signaling in corneal neovascularization. Cornea. 2013;32:674-679.
9. Pearlman E, Hall LR. Immune mechanisms in Onchocerca volvulus-mediated corneal disease (river blindness). Parasite Immunol. 2000;22:625-631.
10. Tshionyi M, Shay E, Lunde E, et al. Hemangiogenesis and lymphangiogenesis in corneal pathology. Cornea. 2012;31:74-80.
11. Bachmann B, Taylor RS, Cursiefen C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology. 2010;117:1300-1305, e1307.
12. Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor 1. Nature. 2006;443:993-997.
13. Dell S, Peters S, Muther P, Kociok N, Joussen AM. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization. Invest Ophthalmol Vis Sci. 2006;47:1928-1937.
14. Detry B, Blacher S, Erpicum C, et al. Sunitinib inhibits inflammatory corneal lymphangiogenesis. Invest Ophthalmol Vis Sci. 2013;54:3082-3093.
15. Akar EE, Oner V, Kucukerdonmez C, Aydin Akova Y. Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model. Int J Ophthalmol. 2013;6:136-140.
16. Aldave AJ. The genetics of the corneal dystrophies. Dev Ophthalmol. 2011;48:51-66.
17. Aldave AJ, Sonmez B. Elucidating the molecular genetic basis of the corneal dystrophies: are we there yet? Arch Ophthalmol. 2007;125:177-186.
18. Lisch W, Seitz B. New international classification of corneal dystrophies (CD) [in German]. Ophthalmologe. 2011;108: 883-896, quiz 897.
19. Vauclair S, Majo F, Durham AD, Ghyselinck NB, Barrandon Y, Radtke F. Corneal epithelial cell fate is maintained during repair by Notch1 signaling via the regulation of vitamin A metabolism. Dev Cell. 2007;13:242-253.
20. Kao WW, Liu CY. Roles of lumican and keratocan on corneal transparency. Glycoconj J. 2002;19:275-285.
21. Kao WW, Liu CY, Converse RL, et al. Keratin 12-deficient mice have fragile corneal epithelia. Invest Ophthalmol Vis Sci. 1996;37:2572-2584.
22. Murphy MJ, Polok BK, Schorderet DF, Cleary ML. Essential role for Pbx1 in corneal morphogenesis. Invest Ophthalmol Vis Sci. 2010;51:795-803.
23. Hahn N, Dietz CT, Kuhl S, Vossmerbaeumer U, Kroll J. KLEIP deficiency in mice causes progressive corneal neovascular dystrophy. Invest Ophthalmol Vis Sci. 2012;53:3260-3268.
24. Samolov B, Kvanta A, van der Ploeg I. Delayed neovascularization in inflammation-induced corneal neovascularization in interleukin-10-deficient mice. Acta Ophthalmol. 2010;88:251-256.
25. Bachmann BO, Bock F, Wiegand SJ, et al. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol. 2008;126:71-77.
26. Azar DT. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2006;104:264-302.
27. Zhang Y, Call MK, Yeh LK, et al. Aberrant expression of a betacatenin gain-of-function mutant induces hyperplastic transformation in the mouse cornea. J Cell Sci. 2010;123:1285-1294.
28. Qazi Y, Stagg B, Singh N, et al. Nanoparticle-mediated delivery of shRNA. VEGF-a plasmids regresses corneal neovascularization. Invest Ophthalmol Vis Sci. 2012;53:2837-2844.
29. Kim IT, Park HY, Choi JS, Joo CK. Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models. Invest Ophthalmol Vis Sci. 2012;53:3111-3119.
30. Yu L, Wu X, Cheng Z, et al. Interaction between bevacizumab and murine VEGF-A: a reassessment. Invest Ophthalmol Vis Sci. 2008;49:522-527.
31. Basu A, Contreras AG, Datta D, et al. Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer. Cancer Res. 2008;68:5689-5698.
32. Rodriguez-Pazos L, Ginarte M, Vega A, Toribio J. Autosomal recessive congenital ichthyosis. Actas Dermosifiliogr. 2013; 104:270-284.
33. Akiya S, Furukawa H, Sakamoto H, Takahashi H, Sakka Y. Histopathologic and immunohistochemical findings in gelatinous drop-like corneal dystrophy. Ophthalmic Res. 1990;22: 371-376.
34. Hasegawa M, Higashi K, Matsushita T, et al. Dermokine inhibits ELR(+)CXC chemokine expression and delays early skin wound healing. J Dermatol Sci. 2013;70:34-41.
35. Li S, Nikulina K, DeVoss J, et al. Small proline-rich protein 1B (SPRR1B) is a biomarker for squamous metaplasia in dry eye disease. Invest Ophthalmol Vis Sci. 2008;49:34-41.
36. Wu M, McClellan SA, Barrett RP, Zhang Y, Hazlett LD. Betadefensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J Immunol. 2009;183:8054-8060.
37. Hughes AE, Bradley DT, Campbell M, et al. Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am J Hum Genet. 2011;89:628-633.
38. Conte I, Carrella S, Avellino R, et al. miR-204 is required for lens and retinal development via Meis2 targeting. Proc Natl Acad Sci U S A. 2010;107:15491-15496.
39. Ryan DG, Oliveira-Fernandes M, Lavker RM. MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis. 2006;12:1175-1184.
40. Hoffmann A, Huang Y, Suetsugu-Maki R, et al. Implication of the miR-184 and miR-204 competitive RNA network in control of mouse secondary cataract. Mol Med. 2012;18:528-538.
41. Shalom-Feuerstein R, Serror L, De La Forest Divonne S, et al. Pluripotent stem cell model reveals essential roles for miR-450b-5p and miR-184 in embryonic corneal lineage specification. Stem Cells. 2012;30:898-909.
42. Iliff BW, Riazuddin SA, Gottsch JD. A single-base substitution in the seed region of miR-184 causes EDICT syndrome. Invest Ophthalmol Vis Sci. 2012;53:348-353.
43. Wang FE, Zhang C, Maminishkis A, et al. MicroRNA-204/211 alters epithelial physiology. FASEB J. 2010;24:1552-1571.
44. Dweep H, Sticht C, Pandey P, Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform. 2011;44:839-847.
45. Kanayama S, Nishida K, Yamato M, et al. Analysis of angiogenesis induced by cultured corneal and oral mucosal epithelial cell sheets in vitro. Exp Eye Res. 2007;85:772-781.
46. Morisada T, Oike Y, Yamada Y, et al. Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood. 2005;105: 4649-4656.
47. Jeansson M, Gawlik A, Anderson G, et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest. 2011;121:2278-2289.